Elbion Overview
- Founded
- 2002
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $18M
Elbion General Information
Description
Provider of pharmaceutical research and development services. The company operates as a specialty pharmaceutical company focused on the development and commercialization of therapeutics for neurological diseases and immunological disorders.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- Meissner Straße 191
- 01445 Radebeul
- Germany
+49 0351 00000
Elbion Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 14-Nov-2008 | $18M | 000.00 | 0000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 10-Jul-2005 | 000.00 | 000.00 | Completed | Generating Revenue |
Elbion Patents
Elbion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2706986-A1 | Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 | Abandoned | 30-Nov-2007 | 0000000000 | |
| AU-2008329072-A1 | Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 | Abandoned | 30-Nov-2007 | 0000000000 | |
| US-20090143391-A1 | Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10 | Abandoned | 30-Nov-2007 | 0000000000 | 0 |
| US-20090143392-A1 | Methods of treating obesity and metabolic disorders | Abandoned | 30-Nov-2007 | 00000000000 | 0 |
| EP-2227472-A1 | Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 | Withdrawn | 30-Nov-2007 | C07D487/04 |
Elbion Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Bernd Kastler | Chief Executive Officer |
Elbion Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Luc Philips | Self | Chairman | 000 0000 |
Elbion Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 3i Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| BayTech Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Burrill & Co | Merchant Banking Firm | Minority | 000 0000 | 000000 0 | |
| Deutsche Venture Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Idinvest Partners | PE/Buyout | Minority | 000 0000 | 000000 0 |
Elbion Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 19-Jan-2007 | 000000000 | Buildings and Property | 00000 000 | |
| 4 AZA Bioscience | 12-Aug-2006 | Merger/Acquisition | Biotechnology |